Skip to main content
. 2025 Jul 23;23:439. doi: 10.1186/s12916-025-04231-7

Table 1.

Umbilical cord allograft suspension mediator content as determined by ELISA

Mediator (pg/mL) Mean ± SEM Coefficient of variance within donor (CV %)
IFNg 184.5 ± 32.1 30.1
IL-1a 969.3 ± 5.9 1.1
IL-1ra 317.9 ± 15.6 8.5
IL-1ra/IL-1a 0.3 ± 0.02 9.6
IL-2 839.7 ± 19.9 4.1
IL-4 85.5 ± 21.7 43.9
IL-8 870.8 ± 30.4 6.1
IL-10 95.1 ± 22.5 40.9
IL-15 689.2 ± 20.3 5.1
MCP 1175.8 ± 25.7 3.8
VEGF 833.7 ± 26.0 5.4
HA 42.3 ± 3.6 14.9

N = 3; samples run in triplicate

IFNg interferon gamma,

IL-1 interleukin-1a,

IL-1ra interleukin-1 receptor antagonist,

IL-2, −4, −8, −10, and −15 the corresponding interleukin,

MCP-1 monocyte chemoattractant protein-1,

VEGF vascular endothelial growth factor,

HA hyaluronic acid